Use of Serum Protein Measurements as Biomarkers That Can Predict the Outcome of Diabetic Foot Ulceration.

To identify proteins that are prognostic for diabetic foot ulcer (DFU) healing and may serve as biomarkers for its management serum samples were analyzed from diabetic (DM) patients. The serum specimens that were evaluated in this study were obtained from DM patients with DFU who participated in a prospective study and were seen bi-weekly until they healed their ulcer or the exit visit at 12 weeks. The group was divided into Healers (who healed their DFU during the study) and Non-Healers. IL-10, IL-4, IL-5, IL-6, IL-13 and INFγ, were higher in the Healers while Fractalkine, IL-8, and TNFα were higher in the Non-Healers. The trajectory of IL-10 levels remained stable over time within and across groups, resulting in a strong prognostic ability for the prospective DFU healing course. Classification and Regression Tree (CART) analysis created an 11-node decision tree with healing status as the categorical response. Consecutive measurements of proteins associated with wound healing can identify biomarkers that can predict DFU healing over a 12-week period. IL-10 was the strongest candidate for prediction. Measurement of serum proteins can serve as a successful biomarker in guiding clinical management of DFU. The data also indicate likely superior performance of building a multi-protein biomarker score instead of relying on single biomarkers.